Protecting Vaccine Shipments in 2026: What the Next Era of Cold Chain Looks
As 2026 approaches, the pharmaceutical industry faces a new test in vaccine logistics. The lessons of recent years have shown just how fragile global cold…
Pharma
Agentic AI: How can Pharma Harness its Coordinated Reasoning?
With agentic AI, the promise is about so much more than process enhancement and greater productivity. It is about redefining a function’s purpose and value,…
Statistical Significance: Could Small Pharma Companies be making more of Safety Signal Detection?
It’s becoming increasingly clear that minimal signal detection is not cutting it, when it comes to doing the best for patients and staying ahead of…
Why Small Parcels are a Big Test for Contract Pharma
In today’s pharmaceutical landscape, complexity is the new normal. With decentralised clinical trials, personalised medicines and direct-to-patient therapies on the rise, pharma supply chains must…
The Next Phase in EU ISO IDMP Adoption Affecting Medtech and Connected Health: Product Management Services
As Europe’s implementation of ISO IDMP data standards progresses, EMA’s centralised Product Management Services (PMS) platform is emerging as the next priority for the life…
The Fight to Stop Drug Diversion – How One Non-profit is Changing the System
Drug diversion is rampant in the United States, occurring in nearly every hospital and health system. We spoke with Tom Knight, the Founder and Chairman…
Why Early-Stage Drug Formulation Matters in Clinical Success
Key Takeaways: Early-stage formulation impacts clinical outcomes, cost, and time-to-market. Collaboration and technology integration drive better formulation decisions. Strategic planning can support regulatory compliance and…
In Regulated Industries, The Question Isn’t Whether to Use AI, it’s How to Use it Responsibly
In high stakes, regulated industries the promise of AI is huge – faster decisions, deeper insights, greater efficiency. But so are the risks. When lives, compliance…
From Weight-loss Jabs to Ongoing Covid Vaccine Vigilance: Why an AI Enhanced Approach to Pharmacovigilance Case Processing is now Non-negotiable
AI enabled pharmacovigilance isn’t just about absorbing extra AE case volumes without driving up costs to maintain compliance and mitigate risk. It is also crucial…
How to Avoid the Trap of Digitisation Without Value
Forrester Consulting recently conducted a survey of European pharmaceutical companies commissioned by Hexagon, analysing their priorities and challenges in digital transformation. One of the most…